Trial Profile
An open-label, nonrandomized study to evaluate the potential pharmacokinetic interaction between multiple doses of lecozotan SR [sustained release] and a single oral dose of digoxin when administered orally to healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs Lecozotan (Primary) ; Digoxin
- Indications Alzheimer's disease; Arrhythmias; Heart failure
- Focus Pharmacokinetics
- Sponsors Wyeth
- 08 Sep 2008 Status changed from not yet recruiting to completed as reported by Clinicaltrials.gov.
- 08 Sep 2008 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
- 14 Dec 2007 New trial record.